51 منٹ پہلے
Oscar Slips As LifeStance, HCA Climb On Earnings, Payment Hike
Oscar Health stock fell despite a Q3 earnings beat and raised guidance while LifeStance and HCA extended breakouts on earnings and payment news.
BTC-1.38%
ETH-1.55%
SOL-2.33%
USDC-0.02%
XRP-2.63%
HYPE-6.57%
SUI-4.93%
GRAMTON-5.89%BTC-1.38%ETH-1.55%SOL-2.33%USDC-0.02%XRP-2.63%HYPE-6.57%SUI-4.93%GRAMTON-5.89%BTC-1.38%ETH-1.55%SOL-2.33%USDC-0.02%XRP-2.63%HYPE-6.57%SUI-4.93%GRAMTON-5.89%BTC-1.38%ETH-1.55%SOL-2.33%USDC-0.02%XRP-2.63%HYPE-6.57%SUI-4.93%GRAMTON-5.89%
17 گھنٹے پہلے
Arm Stock: Chip Designer Beats Fiscal Q2 Targets
Arm beat analyst estimates for its fiscal second quarter and with its guidance for the current period. But Arm stock fell.
23 گھنٹے پہلے
CVS Health Is Breaking Up. Is The Blue Wave To Blame?
CVS Health stock dived after announcing it will break off its retail pharmacy business. Congress, under Democrats, may have forced the split.
1 دن پہلے
HCA Healthcare, Centene, Oscar Ride Blue Wave to Buy Points
HCA and Oscar led gains. The market expects Medicaid cuts to be limited. It also expects ACA subsidies to be restored.
1 دن پہلے
Datadog Stock: Datadog Earnings Top Views. Shares Plunge On Weak Sales Outlook.
Datadog stock tanked despite Q3 earnings that easily beat estimates. Q4 revenue guidance fell short and signaled flat sequential growth.
1 دن پہلے
Pfizer CEO Cites $80 Billion in Deals; 'Real Test' Still Ahead
The CEO said $80 billion in deals had been struck. A portfolio manager said the real test was still ahead.
2 دن پہلے
Anthropic IPO Filing Reveals Computing Bill Near $900 Billion
Ahead of the Anthropic IPO, the startup said revenue climbed more than 1,100% to $17 billion in the third quarter.
11-2
Tesla Robotaxi Adds This New City, Stock Continues Rally
Tesla's robotaxi service is now available in seven cities in Texas and Florida. Tesla stock rose about 2% on Monday.
10-30
Eli Lilly CFO On Acquisition Spree: 'We Are Taking Bets' On Future Revenue
Eli Lilly blew past sales expectations Thursday and hiked its outlook on the back of strong performance from Mounjaro and Zepbound.
